Outcomes in elderly patients undergoing hepatic resection compared to liver transplant for hepatocellular carcinoma

Abstract

AbstractBackgroundHepatic resection (HR) is an excellent option for patients with hepatocellular carcinoma (HCC). For patients meeting the Milan criteria, a liver transplant (LT) is also a viable option for patients with HCC, especially those with end‐stage liver disease. With increasing rates of LTs amongst the elderly, we sought to determine long‐term outcomes in patients who underwent HR compared to LTs in this patient population.MethodsWe queried the national cancer database for elderly patients (≥70 years) diagnosed with HCC between 2004 and 2020. The primary outcome was overall survival (OS) computed using the Kaplan−Meier method and Cox proportional hazard regression. One‐to‐one propensity score matching was conducted on the basis of clinicodemographic features to account for baseline differences between patients undergoing each procedure.ResultsOf the 5090 patients included, 4674 (91.8%) and 416 (8.2%) patients underwent HR and LT, respectively. Compared with HR patients, patients receiving LT had better OS (p < 0.001) and greater median survival time (65.6 months HR vs. 97.9 months LT, p < 0.001). On multivariable analysis, a LT was independently associated with improved survival (adjusted hazard ratio: 0.61, 95% confidence interval: 0.50−0.76, p < 0.001).ConclusionsLT is associated with improved survival for well‐selected elderly patients with HCC. Age alone should not be used as the sole parameter for the candidacy of LT in elderly patients.